Exascale Labs Holdings Inc. XLAB
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | 101.62% | 145.75% | 178.51% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 101.62% | 145.75% | 178.51% | ||
| Cost of Revenue | 92.09% | 153.90% | 174.60% | ||
| Gross Profit | 175.41% | 107.12% | 199.46% | ||
| SG&A Expenses | 19.06% | 11.32% | 63.39% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 98.37% | 143.69% | 50.64% | ||
| Operating Income | -89.02% | -136.59% | 56.47% | ||
| Income Before Tax | -71.26% | -134.85% | 50.00% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -71.26% | -134.85% | 50.00% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -71.26% | -134.85% | 50.00% | ||
| EBIT | -89.02% | -136.59% | 56.47% | ||
| EBITDA | -89.24% | -137.12% | 56.58% | ||
| EPS Basic | -- | -- | -- | ||
| Normalized Basic EPS | -- | -- | -- | ||
| EPS Diluted | -- | -- | -- | ||
| Normalized Diluted EPS | -- | -- | -- | ||
| Average Basic Shares Outstanding | -- | -- | -- | ||
| Average Diluted Shares Outstanding | -- | -- | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||